<SEC-DOCUMENT>0000919574-26-002950-index.html : 20260513 <SEC-HEADER>0000919574-26-002950.hdr.sgml : 20260513 <ACCEPTANCE-DATETIME>20260513094444 ACCESSION NUMBER: 0000919574-26-002950 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20260513 DATE AS OF CHANGE: 20260513 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Opus Genetics, Inc. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79996 FILM NUMBER: 26971388 BUSINESS ADDRESS: STREET 1: 8 DAVIS DRIVE STREET 2: SUITE 220 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 248-681-9815 MAIL ADDRESS: STREET 1: 8 DAVIS DRIVE STREET 2: SUITE 220 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Ocuphire Pharma, Inc. DATE OF NAME CHANGE: 20201109 FORMER COMPANY: FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Adage Capital Management, L.P. CENTRAL INDEX KEY: 0001535978 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET, 52ND FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-867-2800 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET, 52ND FLOOR CITY: BOSTON STATE: MA ZIP: 02116 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>d12144635_ex99-1.htm <DESCRIPTION>JOINT FILING STATEMENT <TEXT> Document 2 - file: d12144635_ex99-1.htm
</DOCUMENT> </SEC-DOCUMENT>